EUVIMEDEUVIMED entdecken
Crossref

L26/O-309 Comparative proteomic analysis of commercially available culture media for human preimplantation embryo development

M. Zagers, M. Laverde, T. Pham, G. Kramer, C. Jimenez, S. Mastenbroek

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Zagers und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What is the protein composition of commercially available human preimplantation embryo culture media, supplements, and laboratory-prepared formulations? Summary answer Commercially available embryo culture media and supplements contain numerous undeclared proteins, largely driven by supplement origin, highlighting a lack of transparency in media composition. What is known already Human preimplantation embryo culture media vary significantly in composition, which can influence IVF efficacy and clinical outcomes, including birthweight. While manufacturers typically list human serum albumin (HSA) as the sole protein source, recent evidence indicates that undeclared proteins are present in both supplemented and unsupplemented media. Protein supplementation is vital for stabilizing the culture environment and modulating cellular processes; however, the specific proteomic complexity of these formulations remains poorly characterized. This lack of transparency and standardization hinders our understanding of how specific protein components might drive embryo development and subsequent clinical success. Study design, size, duration A comprehensive set of 47 human embryo culture media and protein supplements was analyzed. Upon arrival, each ready-to-use medium (n = 23), unsupplemented medium (n = 14), and supplement (n = 10) was aliquoted in Eppendorf tubes. Additionally, unsupplemented media were supplemented in house with each available supplement from the same brand (n = 33 combinations). All samples were immediately snap frozen in liquid nitrogen upon receipt and stored at -80 °C prior to high-resolution proteomic analysis. Participants/materials, setting, methods Proteins in the samples were reduced, alkylated, digested, and acidified prior to LC-MS analysis, with no albumin depletion performed. Peptides were analyzed using a TIMS-TOF Pro mass spectrometer. Raw data were processed with MaxQuant and matched with an UniProt proteome database for identification and label-free quantification. Only protein hits supported by ≥ 3 unique peptides were accepted. Functional annotation and classification of molecular functions and biological processes were conducted using gene ontology (GO) terms analysis. Main results and the role of chance Proteomic analysis of 47 commercially available human embryo culture media and supplements and 33 laboratory supplemented media revealed the presence of multiple undeclared proteins across all media types. Unsupplemented media contained between 22 and 57 undeclared proteins. Most protein supplements contained 43–58 undeclared proteins, although marked variations were observed, with a recombinant human albumin supplement (G-MM) containing 5 proteins, and serum substitutes (SPS and SSS) containing 79 and 103 proteins, respectively. Ready-to-use media showed a moderate range of undeclared proteins (36–56), while laboratory supplemented media spanned 8–103 proteins, dictated primarily by the supplement used. The proteomic profile revealed a clear signature of origin: supplements, ready-to-use, and laboratory supplemented media were dominated by high-abundance plasma-derived proteins (e.g., HP, HPX, A1BG). Whereas unsupplemented media were characterized by intracellular proteins (e.g., VIM, GAPDH, ENO1), suggesting different sources of “hidden” proteomic complexity. While our findings provide a detailed map of media composition, they remain descriptive and exploratory. Limitations, reasons for caution The analysis was limited to a single batch per medium without technical replicates; batch-to-batch variation was not assessed. The high concentration of HSA in the different media may have masked low abundant proteins. Wider implications of the findings Profiling the hidden proteome of human embryo culture media reveals undeclared proteins in both supplemented and unsupplemented formulations, varying by product and origin. This incomplete disclosure limits understanding of media effects on embryo development, highlighting the urgent need for transparency and standardization to ensure controlled and reproducible culture conditions. Trial registration number No

Zitieren

APA

Zagers, M., Laverde, M., Pham, T., Kramer, G., Jimenez, C., & Mastenbroek, S. (2026). L26/O-309 Comparative proteomic analysis of commercially available culture media for human preimplantation embryo development. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.307

Vancouver

Zagers M, Laverde M, Pham T, Kramer G, Jimenez C, Mastenbroek S. L26/O-309 Comparative proteomic analysis of commercially available culture media for human preimplantation embryo development. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.307

BibTeX
@article{Zagers2026,
  author = {Zagers, M. and Laverde, M. and Pham, T. and Kramer, G. and Jimenez, C. and Mastenbroek, S.},
  title = {L26/O-309 Comparative proteomic analysis of commercially available culture media for human preimplantation embryo development},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.307}
}
Kostenlos starten →